Raphael Mechoulam
Mechoulam, Raphaël
Mechoulam, Raphael, 1930-2023
רפאל משולם
משולם, רפאל, 1930-2023
VIAF ID: 97368809 (Personal)
Permalink: http://viaf.org/viaf/97368809
Preferred Forms
-
-
-
- 100 1 _ ‡a Mechoulam, Raphael
- 100 1 _ ‡a Mechoulam, Raphael
- 100 1 _ ‡a Mechoulam, Raphael
- 100 1 _ ‡a Mechoulam, Raphael ‡d 1930-2023
- 100 1 _ ‡a Mechoulam, Raphael, ‡d 1930-2023
-
-
-
- 100 0 _ ‡a Raphael Mechoulam
-
- 100 0 _ ‡a רפאל משולם
4xx's: Alternate Name Forms (41)
5xx's: Related Names (6)
- 510 2 _ ‡a International Union of Pure and Applied Chemistry
- 551 _ _ ‡a Jerusalem ‡4 orts ‡4 https://d-nb.info/standards/elementset/gnd#placeOfDeath
- 551 _ _ ‡a Jerusalem ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _ ‡a Sofia ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a ha- Universiṭah ha-ʿIvrit ‡b Faculty of Medicine
- 510 2 _ ‡a ha- Universiṭah ha-ʿIvrit ‡g Jerusalem ‡b Faculty of Medicine ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Albert Einstein memorial lectures | |
Cannabinoids as therapeutics | |
CBD : what does the science say? | |
CBDの科学 : 大麻由来成分の最新エビデンス | |
Fortschritte der Chemie Organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products / Progrès dans la Chimie des Substances Organiques Naturelles | |
Marijuana chemistry, pharmacology, metabolism and clinical effects | |
Meḥkarim ʻal ha-sharsheret ha-tsedadit bi-steroʹidim. | |
n 85063925 | |
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury | |
Neuroscience. Stout guards of the central nervous system | |
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues | |
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation | |
The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain | |
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis | |
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker | |
Novel natural and synthetic ligands of the endocannabinoid system | |
Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats | |
Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass | |
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines | |
Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. | |
The ovulation blocking effect of cannabinoids: Structure-activity relationships | |
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. | |
Peering through the smoke | |
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling | |
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia | |
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice | |
Physiology. A hunger for cannabinoids | |
Plant cannabinoids: a neglected pharmacological treasure trove | |
Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus | |
Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder. | |
Presence of functional cannabinoid receptors in human endocrine pancreas | |
Prohedonic Effect of Cannabidiol in a Rat Model of Depression. | |
The promise of advances in the field of endocannabinoids. | |
Prospects for cannabinoid therapies in basal ganglia disorders | |
Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. | |
Protective Effects of N-Oleoylglycine in a Mouse Model of Mild Traumatic Brain Injury | |
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy | |
Recent Advances in the Chemistry of Hashish | |
Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog | |
Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats | |
Reply | |
Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury | |
[Role of receptor transactivation in the cardioprotective effects of preconditioning and postconditioning]. | |
Search for endogenous ligands of the cannabinoid receptor | |
Shibidi no kagaku : Taima yurai seibun no saishin ebidensu. | |
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain | |
Skeletal anabolic activity of cannabinoid receptor agonists | |
Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family | |
Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats | |
The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. | |
Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs | |
Stereochemical requirements for cannabimimetic activity | |
Stereoelectronic factor in the chloranil dehydrogenation of cannabinoids. Total synthesis of dl-cannabichromene | |
Stereospecific synthesis of (-)-.DELTA.1- and (-)-.DELTA.1(6)-tetrahydrocannabinols | |
Stereospecifically labeled delta1 | |
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor | |
Structure--activity relationships of pyrrole amidine antiviral antibiotics. 1. Modifications of the alkylamidine side chain | |
Suppression of experimental autoimmune encephalomyelitis by cannabinoids | |
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties | |
Synthesis and antitumor activity of quinonoid derivatives of cannabinoids | |
Synthesis of a potential urinary tetrahydrocannabinol metabolite | |
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells. | |
Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities | |
Tetrahydrocannabinol and endocannabinoids in feeding and appetite | |
Todd's achievement. | |
Toward an anandamide transporter | |
Towards cannabinoid drugs. | |
Trends in medicinal chemistry '90 : proceedings of the XIth International Symposium on Medicinal Chemistry, held in Jerusalem, Israel, 2-7 September 1990 | |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility |